AU7615200A - Vasopressin agonist formulation and process - Google Patents

Vasopressin agonist formulation and process

Info

Publication number
AU7615200A
AU7615200A AU76152/00A AU7615200A AU7615200A AU 7615200 A AU7615200 A AU 7615200A AU 76152/00 A AU76152/00 A AU 76152/00A AU 7615200 A AU7615200 A AU 7615200A AU 7615200 A AU7615200 A AU 7615200A
Authority
AU
Australia
Prior art keywords
agonist formulation
vasopressin agonist
vasopressin
formulation
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76152/00A
Inventor
Mahdi Bakir Fawzi
Richard William Saunders
Joseph Kyuwung Yoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of AU7615200A publication Critical patent/AU7615200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU76152/00A 1999-09-27 2000-09-26 Vasopressin agonist formulation and process Abandoned AU7615200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40616599A 1999-09-27 1999-09-27
US09406165 1999-09-27
PCT/US2000/026380 WO2001022969A2 (en) 1999-09-27 2000-09-26 Vasopressin agonist formulation and process

Publications (1)

Publication Number Publication Date
AU7615200A true AU7615200A (en) 2001-04-30

Family

ID=23606805

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76152/00A Abandoned AU7615200A (en) 1999-09-27 2000-09-26 Vasopressin agonist formulation and process

Country Status (7)

Country Link
EP (1) EP1216045A2 (en)
JP (1) JP2003510280A (en)
CN (1) CN1391476A (en)
AU (1) AU7615200A (en)
CA (1) CA2385971A1 (en)
MX (1) MXPA02003191A (en)
WO (1) WO2001022969A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US7700583B2 (en) 2003-04-11 2010-04-20 High Point Pharmaceuticals, Llc 11β-hydroxysteroid dehydrogenase type 1 active compounds
ATE467616T1 (en) * 2003-04-11 2010-05-15 High Point Pharmaceuticals Llc COMPOUNDS WITH ACTIVITY AT 11BETA-HYDROXASTEROID DEHYDROGENASE
TW201444798A (en) 2013-02-28 2014-12-01 必治妥美雅史谷比公司 Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
EP2961746B1 (en) 2013-02-28 2018-01-03 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521173A (en) * 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
BR9811585A (en) * 1997-07-30 2000-09-26 American Home Prod Tricyclic vasopressin agonists
US6090803A (en) * 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
CA2358891A1 (en) * 1999-02-04 2000-08-10 Amedeo Arturo Failli Thienylbenzoylbenzazepines as vasopressin agonists

Also Published As

Publication number Publication date
CA2385971A1 (en) 2001-04-05
MXPA02003191A (en) 2002-09-30
CN1391476A (en) 2003-01-15
EP1216045A2 (en) 2002-06-26
WO2001022969A3 (en) 2001-12-20
JP2003510280A (en) 2003-03-18
WO2001022969A2 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU7989400A (en) Compounds and methods
AU7998900A (en) Automotive-ceiling-mounted monitor
AU3215500A (en) Compounds and methods
AU7490200A (en) New and improved formulation for paclitaxel
AU5326100A (en) Pharmaceutical compositions and methods for use
AU5634300A (en) Composition and films thereof
AU4328800A (en) Pharmaceutical formulation
AU5565099A (en) Pharmaceutical compositions and methods for use
AU1403501A (en) Novel composition and use
AU1043201A (en) Cyclosporin formulation
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU7816000A (en) Pediculocidal and veterinary compositions
AU7615200A (en) Vasopressin agonist formulation and process
AU6647200A (en) Flash-spinning process and solution
AU4198899A (en) Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
AU2207001A (en) Novel compounds and process
AU4543500A (en) Pharmaceutical compositions and uses
AU3839900A (en) Pharmaceutical formulation
AU5979300A (en) Angiopoietin-6 and uses thereof
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
AU2880699A (en) Pharmaceutical compositions and methods for use
IL148541A0 (en) Vasopressin antagonist formulation and process
AU5182099A (en) Pharmaceutical formulation
AU2272401A (en) Nut and nut holder
AU1388501A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase